Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.25
-0.0200-0.05%
Post-market: 41.250.00000.00%16:04 EDT
Volume:25.39K
Turnover:1.05M
Market Cap:1.06B
PE:- -
High:41.51
Open:41.37
Low:41.18
Close:41.27
52wk High:43.52
52wk Low:28.77
Shares:25.80M
Float Shares:25.80M
Volume Ratio:0.08
T/O Rate:0.10%
Dividend:0.29
Dividend Rate:0.70%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

J&J Says Phase 3 Fuzion Trial Shows Tremfya Delivers up to 28% Perianal Fistula Remission in Crohn’s Disease

Reuters
·
Just now

Tremfya® (Guselkumab) Demonstrated Sustained Clinical and Endoscopic Remission Through 3 Years in Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Just now

New Tremfya® (Guselkumab) Study Shows Consistent Perianal Fistula Remission Across Key Crohn's Disease Patient Subgroups

THOMSON REUTERS
·
Just now

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
19 mins ago

Preview: Johnson & Johnson Earnings Expected to Decline in Q3

Reuters
·
1 hour ago

What to Watch in the Day Ahead - Tuesday, October 13

Reuters
·
1 hour ago

Market Chatter: Bristol-Myers Squibb Says Patient Death Likely Unrelated to Admilparent Treatment

MT Newswires Live
·
2 hours ago

RBC says Bristol Myers’ ALOFT-IPF efficacy ‘encouraging, but confounding’

TIPRANKS
·
2 hours ago

Bristol Myers has blockbuster opportunity in IPF, says William Blair

TIPRANKS
·
2 hours ago

Bristol Myers tells Bloomberg admilparent death unlikely due to drug

TIPRANKS
·
2 hours ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and AxoGen (AXGN)

TIPRANKS
·
2 hours ago

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.35% on Oct 12: What Signal Does It Send?

TradingKey
·
3 hours ago

US Stocks on the MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers

Reuters
·
3 hours ago

Eli Lilly Likely to Post Strong Volume Growth in Q3, RBC Says

MT Newswires Live
·
Yesterday

Merck's Recent Commentary Signals 'Modest' 2027 Growth, RBC Says

MT Newswires Live
·
Yesterday

Eli Lilly Price Target Maintained with a $1500.00/Share by RBC Capital

Dow Jones
·
Yesterday

Merck Price Target Cut to $145.00/Share from $150.00 by RBC Capital

Dow Jones
·
Yesterday

Bristol Myers Stock is Rising on a Double Dose of Good News

Dow Jones
·
Yesterday

Bristol Phase 3 success with admilparant should send Contineum up, says Stifel

TIPRANKS
·
Yesterday

Bausch + Lomb CEO Saunders Departs, Chairman Appio Named Interim Chief

Reuters
·
Yesterday